John Fletcher
Board Member
John Fletcher is a founder, advisor, and growth-accelerator with deep knowledge of innovation in healthcare and technology. John’s experience with clients, portfolio companies, and the investment community informs his analytical insights and creative solutions. He has particular interest in devices, specifically in cardiology, cardiac surgery, and orthopedics, as well as in biopharma and healthcare IT.
John founded Fletcher Spaght in 1983 to provide specialized expertise focused on revenue growth and future growth potential to clients managing healthcare, technology, and mature industry companies. He currently serves as managing partner at Fletcher Spaght, leading both the consulting practice and venture capital activities. Prior to founding Fletcher Spaght, John was a Senior Manager at The Boston Consulting Group, advising a broad range of companies in healthcare and high technology industries.
John currently serves as the Chairman of ClearPoint Neuro, Koru Medical, and Metabolon. Previously, he served as Chairman of Spectranetics during its turnaround and subsequent sale to Philips N.V.
John holds an MBA from Southern Illinois University, a MBA in International Finance from Central Michigan University, and a BBA in Marketing from George Washington University. He was an instructor for courses in international business and a PhD Candidate at the Wharton School of the University of Pennsylvania. John served as a Captain and jet pilot in the U.S. Air Force and continues to be active in aviation.
Linkedin